CUAMC
GRNA

China Universal Asset Management Company’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

China Universal Asset Management Company’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,988
Closed -$593 – 463
2023
Q2 		$593 Sell
1,988
-66
-3% -$20 ﹤0.01% 450
2023
Q1 		$888 Buy
2,054
+515
+33% +$395 ﹤0.01% 442
2022
Q4 		$1.82K Buy
+1,539
New +$2.51K ﹤0.01% 379

China Universal Asset Management Company's GRNA Position: Q3 2023 in Review

China Universal Asset Management Company sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 1,988 shares — an estimated $593 sold.

China Universal Asset Management Company first reported a position in GRNA in Q4 2022 and held it in 3 quarters. The position peaked at $1.82K in Q4 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

  • China Universal Asset Management Company reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 1,988 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $593.
  • China Universal Asset Management Company first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q4 2022 and held it in 3 quarters.
  • China Universal Asset Management Company's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $1.82K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on China Universal Asset Management Company's 13F filing for Q3 2023, filed 31 Oct 2023.